• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Science. Hemagglutinin Receptor Binding Avidity Drives Influenza A Virus Antigenic Drift

Giuseppe

Emeritus
Hemagglutinin Receptor Binding Avidity Drives Influenza A Virus Antigenic Drift (Science, abstract, edited)

Science 30 October 2009: Vol. 326. no. 5953, pp. 734 - 736
DOI: 10.1126/science.1178258

Hemagglutinin Receptor Binding Avidity Drives Influenza A Virus Antigenic Drift

Scott E. Hensley,1 Suman R. Das,1 Adam L. Bailey,1 Loren M. Schmidt,1 Heather D. Hickman,1 Akila Jayaraman,2 Karthik Viswanathan,2 Rahul Raman,2 Ram Sasisekharan,2 Jack R. Bennink,1 Jonathan W. Yewdell1,*


Rapid antigenic evolution in the influenza A virus hemagglutinin precludes effective vaccination with existing vaccines. To understand this phenomenon, we passaged virus in mice immunized with influenza vaccine. Neutralizing antibodies selected mutants with single?amino acid hemagglutinin substitutions that increased virus binding to cell surface glycan receptors. Passaging these high-avidity binding mutants in na?ve mice, but not immune mice, selected for additional hemagglutinin substitutions that decreased cellular receptor binding avidity. Analyzing a panel of monoclonal antibody hemagglutinin escape mutants revealed a positive correlation between receptor binding avidity and escape from polyclonal antibodies. We propose that in response to variation in neutralizing antibody pressure between individuals, influenza A virus evolves by adjusting receptor binding avidity via amino acid substitutions throughout the hemagglutinin globular domain, many of which simultaneously alter antigenicity.

1 Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892, USA.
2 Harvard-MIT Division of Health Sciences and Technology, Koch Institute for Integrative Cancer Research and Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
* To whom correspondence should be addressed. E-mail: jyewdell@mail.nih.gov
-
<cite cite="http://www.sciencemag.org/cgi/content/abstract/326/5953/734">Hemagglutinin Receptor Binding Avidity Drives Influenza A Virus Antigenic Drift -- Hensley et al. 326 (5953): 734 -- Science</cite>
 
Back
Top